ring finger protein 152 pseudogene 1Genealiases: []
Q-omics provides the consensus-scored RNF152P1 profile across patient tissues and cancer cell-line models. RNF152P1 expression is associated with patient survival in 23 of 34 cancer types, with the highest sampling consensus in DLBC. Among the 18 cancer types available for tumor–normal comparison, RNF152P1 is differentially expressed in 7, with the highest sampling consensus in HNSC. Additionally, RNF152P1 RNA expression shows 6,278 significant gene co-expression associations, with the highest sampling consensus in LAML. Together, these results highlight DLBC, HNSC, and LAML as cancer lineages where RNF152P1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RNF152P1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes RNF152P1 survival associations across molecular data types. RNF152P1 RNA expression shows survival associations in the most cancer types (23). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RNF152P1 RNA expression–survival associations across cancer types. High RNF152P1 expression shows unfavorable associations in DLBC and LUSC, but favorable associations in BRCA, PAAD, MESO and UCS. The DLBC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify DLBC as the clearest survival context for RNF152P1 RNA expression.
This table summarizes RNF152P1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 7. The strongest signals are observed in HNSC for RNA.
This table ranks reproducible tumor–normal expression differences for RNF152P1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. RNF152P1 shows lower tumor expression in KIRC and higher tumor expression in HNSC, BLCA, LUSC, STAD and ESCA. The HNSC box plot shows higher RNF152P1 RNA expression in tumor versus normal tissue (log2 FC = +0.122, t-test p = .011).
This table shows molecular features associated with RNF152P1 in patient tissues and cancer cell lines. In patient samples, RNF152P1 shows the broadest associations at the RNA and protein expression levels, with LAML recurring as the lineage with the largest associated feature set.
